IRIS
DE FERRARI, GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.574
EU - Europa 2.331
AS - Asia 2.080
AF - Africa 8
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 8.003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.507
CN - Cina 2.044
IE - Irlanda 1.023
FI - Finlandia 309
IT - Italia 278
DE - Germania 240
UA - Ucraina 224
SE - Svezia 95
GB - Regno Unito 82
CA - Canada 67
FR - Francia 31
IN - India 22
BE - Belgio 21
AT - Austria 8
NL - Olanda 5
RU - Federazione Russa 5
AU - Australia 4
MU - Mauritius 4
MY - Malesia 4
ES - Italia 3
EU - Europa 3
KE - Kenya 3
BR - Brasile 2
DK - Danimarca 2
HK - Hong Kong 2
IR - Iran 2
PL - Polonia 2
RO - Romania 2
SG - Singapore 2
TR - Turchia 2
GR - Grecia 1
IQ - Iraq 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
VN - Vietnam 1
Totale 8.003
Salva come PNG Salva come JPEG
Città #
Dublin 1.021
Chandler 746
Nanjing 655
Jacksonville 596
Ashburn 273
Nanchang 260
Princeton 206
Lawrence 198
Medford 187
Shenyang 172
Wilmington 172
Changsha 170
Hebei 155
Jiaxing 145
Beijing 139
Helsinki 138
Hangzhou 103
Tianjin 100
Pavia 79
Ann Arbor 77
New York 56
Mcallen 52
Munich 39
Montréal 37
Norwalk 37
Boardman 36
Dearborn 33
Woodbridge 33
Fairfield 32
Milan 30
Shanghai 30
Seattle 21
Ottawa 18
Brussels 17
Los Angeles 17
Jinan 14
Pune 14
Redwood City 14
Verona 14
Des Moines 11
Zhengzhou 11
Chieti 10
Ningbo 10
Toronto 10
Kunming 9
Guangzhou 8
Washington 8
Catanzaro 7
Pescara 7
Changchun 6
Fuzhou 6
Rome 6
Vienna 6
Auburn Hills 5
Leuven 4
Orange 4
Berlin 3
Ferrara 3
Melbourne 3
Seregno 3
Seri Kembangan 3
Taizhou 3
Walnut 3
Bari 2
Barletta 2
Biassono 2
Bologna 2
Borås 2
Copenhagen 2
Eden Prairie 2
Florence 2
Francavilla Al Mare 2
Gmunden 2
Hanover 2
Hefei 2
Kemerovo 2
Lodz 2
Monmouth Junction 2
Montoro 2
Napoli 2
New Delhi 2
Novokuznetsk 2
Palermo 2
Rio de Janeiro 2
San Francisco 2
Sant'Angelo Lodigiano 2
Scuola 2
Tabriz 2
Torino 2
Alba 1
Alghero 1
Amsterdam 1
Andover 1
Aquila 1
Arcore 1
Arnesano 1
Benevento 1
Buffalo 1
Cadrezzate 1
Caher 1
Totale 6.348
Salva come PNG Salva come JPEG
Nome #
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 219
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 213
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 92
Gene symbol: KCNH2 83
Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes 74
Atrial arrhythmias prevalence in heart transplant patients. 69
Successful repair of lateral wall pseudoaneurysm via left anterior minithoracotomy using port-access tecnique 69
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 69
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 68
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 66
Remote ischemic postconditioning as a strategy to reduce acute kidney injury during primary PCI: A post-hoc analysis of a randomized trial 63
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 62
A challenging case of permanent junctional reciprocating tachycardia (pjrt) in post-partum cardiogenic shock 62
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis 62
Significant left ventricular reverse remodelling following radiofrequency ablation of monomorphic ventricular ectopy in pts with idiopathic cardiomyopathy 60
Gene symbol: SCN5A 60
Effects of Intra-Aortic Balloon Pump on Markers of Right Ventricular Dysfunction Among End-Stage Heart Failure Patients Candidates to Cardiac Transplant or Ventricular Assist Device 59
Chronic vagus nerve stimulation (CVNS) – A new target for treatment of congestive heart failure. 59
Thromboembolism after atrioventricular node ablation and pacing: long term follow up. 58
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease 58
Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. 57
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 56
Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events 56
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. 55
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients with Stable Ischemic Heart Disease and Previous Myocardial Infarction 55
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 55
Past and future of the "Pavia eCPR program" 55
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 55
[Vagus nerve stimulation for the treatment of heart failure] 55
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. 54
Use of extracorporeal membrane oxygenation in primary refractory cardiac shock and cardiac arrest; a single centre experience 54
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. 54
Prevalence and features of incessant atrial arrhythmias after heart transplantation with standard technique. 53
Hospital survival and long term quality of life after emergency institution of venoarterial ECMO for refractory circulatory collapse. 53
Gene symbol: KCNH2 53
High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study. 52
Two-to-one AV block associated with the congenital long QT syndrome. 52
Prevalenza della aritmie atriali nei pazienti sottoposti a trapianto cardiaco ortotopico secondo la tecnica di Lower e Shumway 52
Autonomic Modulation for the Management of Patients with Chronic Heart Failure 52
Acute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction 52
Gene symbol: KCNQ1 52
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis 52
Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. 51
Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems 51
Left cardiac sympathetic denervation in patients with heart failure: A new indication for an old intervention? 51
Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. 50
Impaired baroreflex sensitivity is correlated with hemodynamic deterioration of sustained ventricular tachycardia. 50
Autonomic nervous system and arrhythmias. 50
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. 50
Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. 49
Protective effect of vagal hyperactivity on reperfusion arrhythmias 49
Extracorporeal membrane oxigenation support decreases mortality in acute myocardial infarction complicated by refractory cardiogenic shock 49
[Sudden death after myocardial infarction. Prediction based on the baroreceptor reflex]. 49
Rapid recovery of baroreceptor reflexes in acute myocardial infarction is a marker of effective tissue reperfusion 49
Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. 49
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 49
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 49
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 49
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 49
Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy 48
Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. 48
End-tidal carbon dioxide and defibrillation success in out-of-hospital cardiac arrest 48
Vagal stimulation for heart failure: background and first in-man study. 47
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 47
Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI 47
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 47
IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results 47
Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. 46
Autonomic reflexes and ventricular tachycardia. 46
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 46
Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs 45
Amiodarone 45
Arterial baroreflexes and ventricular tachycardia. 45
Long term vagal stimulation in patients with advanced heart failure: first experience in man. 44
Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure. 44
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 44
Letter by Ferrari et al regarding article, "long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction" 44
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. 43
Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. 43
Contemporary data on treatment practices for low-density lipoprotein cholesterol in 3867 patients who had suffered an acute coronary syndrome across the world 43
Le cicatrici degli interventi chirurgici di compartimentalizzazione atriale possono condurre a distanza dalla procedura? 43
Baroreflex sensitivity, but not heart rate variability, is reduced in patients with life-threatening ventricular arrhythmias long after myocardial infarction. 42
Vox clamantis in deserto. We spoke but nobody was listening: echocardiography can help risk stratification of the long-QT syndrome. 42
Gene symbol: SCN5A. 42
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 42
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 42
Pathophysiological rationale for cardiac vagal denervation in the treatment of atrial fibrillation 41
Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 41
Carbon monoxide and lethal arrhythmias in conscious dogs with a healed myocardial infarction. 41
Vagal stimulation in heart failure 40
Amiodarone in the treatment of Atrial Fibrillation: New Perspectives from Clinical Trials 40
QT interval and baroreflex sensitivity in conscious dogs before and after myocardial infarction 40
Calmodulin mutations associated with recurrent cardiac arrest in infants. 40
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial 40
Cardiovascular Safety and Efficacy of the PCSK9 Inhibitor Evolocumab in Diabetes and the Risk of Development of Diabetes: A Prespecified Analysis from the Randomized Controlled FOURIER Trial 40
Post-partum cardiogenic shock in a patient with permanent junctional re-entry tachycardia. 39
Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. 38
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 38
Unsuspected echocardiographic abnormality in the long QT syndrome. Diagnostic, prognostic, and pathogenetic implications. 37
Long QT syndrome, a purely electrical disease? Not anymore. 37
Totale 5.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.427
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201955 0 0 0 0 0 0 0 0 0 0 8 47
2019/20202.442 744 1.062 4 52 10 54 20 97 6 190 153 50
2020/2021627 57 38 12 44 21 56 3 191 14 128 53 10
2021/2022791 10 1 14 14 5 27 9 51 46 16 121 477
2022/20232.402 306 164 22 153 197 216 2 105 1.154 15 48 20
2023/2024833 54 258 24 56 62 248 34 59 6 32 0 0
Totale 8.315